Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Sep 27, 2016, 08:30 ET XTL Biopharmaceuticals Reports Second Quarter 2016 Financial Results & Provides Clinical and Operational Update

 XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTLB.TA) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company developing its...


Sep 27, 2016, 08:30 ET New Study Opens Window for OncBioMune Cancer Vaccine in Early and Advanced Prostate Cancer Patients

By: Sara Bowman, Staff Writer, FinancialPress.com BATON ROUGE, LA, Sept. 27, 2016 /PRNewswire/ - Treatment for newly diagnosed prostate...


Sep 27, 2016, 08:15 ET BeyondSpring Announces First Patient Enrolled in Phase 1b/2 Investigator-Initiated Trial of Plinabulin plus Nivolumab for Non-Small Cell Lung Cancer

 BeyondSpring Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer...


Sep 27, 2016, 08:00 ET Daiichi Sankyo to Present at ESMO 2016 Late-Breaking Clinical Data for Novel HER2-Targeting Antibody Drug Conjugate in T-DM1 Pre-Treated Breast Cancer

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that safety and preliminary efficacy phase 1 data evaluating DS-8201a,...


Sep 27, 2016, 07:15 ET ProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) From CRT Pioneer Fund, UK

- PNT737 Currently in Phase 1 Clinical Trials at the Royal Marsden, London, UK - Potential to Exploit Cancer-Driving Genetic Mutations to Achieve...


Sep 27, 2016, 07:00 ET ProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) from CRT Pioneer Fund, UK

- PNT737 currently in Phase 1 clinical trials at the Royal Marsden, London, UK - - Potential to exploit cancer-driving genetic mutations to achieve...


Sep 27, 2016, 07:00 ET Asterias Biotherapeutics Announces Dosing of First Patient in New SCiSTAR Clinical Trial Cohort Testing AST-OPC1 in an Expanded Cervical Spinal Cord Injury Patient Population

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced that the...


Sep 27, 2016, 07:00 ET AcelRx Initiates Phase 3 Study of Zalviso® in Patients with Moderate-to-Severe Acute Post-Operative Pain

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...


Sep 27, 2016, 06:48 ET Harpoon Medical va présenter une mise à jour sur une étude de faisabilité initiale avec 1 an de suivi au congrès 2016 EACTS

BALTIMORE, 27 septembre 2016 /PRNewswire/ -- La société Harpoon Méical, Inc., développeur du système de réparation...


Sep 27, 2016, 06:00 ET Ansun BioPharma Announces Two Publications Showing Inhibitory Effects of DAS181 on Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV)

Ansun BioPharma announced today the publication of two reports by researchers showing potent inhibitory effect of DAS181 on respiratory syncytial...


Sep 27, 2016, 04:00 ET Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients

Amgen (NASDAQ:AMGN) today announced top-line results of the Phase 3 CLARION trial, which evaluated an investigational regimen of...


Sep 27, 2016, 04:00 ET OGT simplifie la détection de variantes génétiques majeures favorisant le cancer

Oxford Gene Technology (OGT), société spécialisée dans la génétique moléculaire, vient de lancer ses panels de...


Sep 27, 2016, 04:00 ET OGT simplifica la detección de importantes variantes de genes de cáncer

Oxford Gene Technology (OGT), The Molecular Genetics Company, ha lanzado sus SureSeq myPanel™ NGS Custom Cancer Panels que proporcionan a...


Sep 27, 2016, 04:00 ET OGT vereinfacht die Erkennung von wichtigen Krebsgenvarianten

Oxford Gene Technology (OGT), The Molecular Genetics Company (das Unternehmen für molekulare Genetik), hat seine SureSeq myPanel™ NGS...


Sep 26, 2016, 17:15 ET Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced initial clinical and new preclinical data for IPI-549, an orally administered...


Sep 26, 2016, 16:05 ET Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Studies of JZP-110 Evaluating Excessive Sleepiness in Obstructive Sleep Apnea

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that patient enrollment has been completed for its two Phase 3 studies evaluating...


Sep 26, 2016, 12:53 ET Enzyme Hyaluronidase Shows Promise as Treatment for Muscle Stiffness Caused by Brain Injury

 A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling...


Sep 26, 2016, 11:25 ET The Michael J. Fox Foundation Selected As Finalist In Competition To Raise Awareness Of Clinical Trial Participation

 The Michael J. Fox Foundation for Parkinson's Research (MJFF) is one of 14 finalists selected to attend the "Inspiring Hope" Ideathon, an...


Sep 26, 2016, 09:07 ET FDA Approves STELARA® (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease

 Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the...


Sep 26, 2016, 09:05 ET MabVax Therapeutics HuMab-5B1 Based Diagnostic Imaging and Radioimmunotherapy Programs Featured at the 2016 World Molecular Imaging Congress

 MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage oncology drug development company, announces that its lead antibody...


Sep 26, 2016, 09:00 ET Positive Results from Use of AirXpanders' AeroForm® Tissue Expander System Highlighted at ASPS Annual Meeting

 AirXpanders Inc. (ASX: AXP), a company developing a novel technology for women undergoing tissue expansion for breast reconstruction following...


Sep 26, 2016, 09:00 ET Mast Therapeutics Provides Business Update

 Mast Therapeutics, Inc. (NYSE MKT: MSTX) today provided an update related to its business strategy and the clinical development of its product...


Sep 26, 2016, 09:00 ET Regentis Receives IDE Approval for Pivotal GelrinC Clinical Trial

Regentis Biomaterials, a developer of hydrogels for tissue regeneration, announced it has received U.S. Food and Drug Administration (FDA)...


Sep 26, 2016, 08:30 ET New Vaccine-Focused Company Aims To End Herpes

Rational Vaccines (RVx), a new biotechnology startup, aims to stop the spread of herpes and improve treatment options for millions of people who...


Sep 26, 2016, 08:00 ET New SonicOne® O.R. Data Being Presented at WUWHS 2016 Congress: Shows Effectiveness in Removing Biofilm

 Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative...